Contribution: Industrial Research Assistance Program – Contributions to Firms
Panthera CryoSolutions Inc.
$391,527.00
Developing Ice Recrystallization Inhibitors for the Cryopreservation of Cell Therapies
FY 2022-23 · 2023-02-01
Summary
PanTHERA has developed a first-of-its-kind technology that improves the cryopreservation of biological materials. The firm is currently able to manufacture research-grade product at small/medium scale.
Briefly, in this project the firm will:
a) increase the manufacturing scale,
b) optimize the manufacturing process, equipment, infrastructure and materials so they follow Good Manufacturing Practices (GMP),
c) develop and validate appropriate quality control tests that prove the quality of the final product, and
d) demonstrate non-biased effectiveness of its product relative to commercially available alternatives via third party evaluations.
The completion of this project will enable PanTHERA to initiate the commercialization of its product.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Spruce Grove|Spruce Grove, Alberta, Canada
Recipient Type
For-profit organization
Business Number
793208711
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2023-02-01 | 2022-23 | $395,700.00 |
| 1 | 2023-02-01 | 2022-23 | $391,527.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 31 days. The total amended value is -4,173 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 31 jours. La valeur totale des modifications est de - 4 173 dollars.
Agreement End Date
2024-03-31
Agreement Number
1001568
Agreement Start Date
2023-02-01
Agreement Title
Developing Ice Recrystallization Inhibitors for the Cryopreservation of Cell Therapies
Agreement Title (French)
Développement d’inhibiteurs de recristallisation de la glace pour la cryoconservation des thérapies cellulaires
Agreement Type
Contribution
Agreement Value
$391,527.00
Amendment Date
2024-02-12
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
PanTHERA has developed a first-of-its-kind technology that improves the cryopreservation of biological materials. The firm is currently able to manufacture research-grade product at small/medium scale.
Briefly, in this project the firm will:
a) increase the manufacturing scale,
b) optimize the manufacturing process, equipment, infrastructure and materials so they follow Good Manufacturing Practices (GMP),
c) develop and validate appropriate quality control tests that prove the quality of the final product, and
d) demonstrate non-biased effectiveness of its product relative to commercially available alternatives via third party evaluations.
The completion of this project will enable PanTHERA to initiate the commercialization of its product.
Description (French)
PanTHERA a mis au point une technologie unique en son genre qui améliore la cryoconservation des matériaux biologiques. L’entreprise est actuellement en mesure de fabriquer des produits de qualité recherche à petite et moyenne échelle. En bref, dans le cadre de ce projet, l’entreprise va : a) augmenter l’échelle de fabrication, b) optimiser le processus de fabrication, l’équipement, l’infrastructure et les matériaux afin qu’ils respectent les bonnes pratiques de fabrication (BPF), c) développer et valider des tests de contrôle de qualité appropriés qui prouvent la qualité du produit final, et d) démontrer l’efficacité non biaisée de son produit par rapport aux alternatives disponibles dans le commerce via des évaluations par des tiers. L’achèvement de ce projet permettra à PanTHERA de lancer la commercialisation de son produit.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Sturgeon River--Parkland
Federal Riding (French)
Sturgeon River--Parkland
Federal Riding Number
48033
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
793208711
Recipient City
Spruce Grove|Spruce Grove
Recipient Country
CA
Recipient Legal Name
Panthera CryoSolutions Inc.
Recipient Postal Code
T7X 0A3
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2022-2023-Q4-1001568
